1. |
CCDC170 |
ENSGALG00000012971 |
105 |
7 |
- |
- |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
1.000 |
- |
1.000 |
coiled-coil domain containing 170 [Source:HGNC Symbol;Acc:HGNC:21177] |
2. |
TOLLIP |
ENSGALG00000006697 |
917 |
0.841 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.841 |
toll interacting protein [Source:NCBI gene;Acc:423099] |
3. |
FBXW4 |
ENSGALG00000043428 |
300 |
0.816 |
- |
- |
- |
- |
- |
0.816 |
- |
- |
- |
- |
F-box and WD repeat domain containing 4 [Source:HGNC Symbol;Acc:HGNC:10847] |
4. |
SPRY2 |
ENSGALG00000016906 |
760 |
0.803 |
- |
- |
- |
- |
- |
0.803 |
- |
- |
- |
- |
sprouty RTK signaling antagonist 2 [Source:NCBI gene;Acc:395584] |
5. |
CYP26C1 |
ENSGALG00000043213 |
87 |
0.802 |
- |
- |
- |
- |
- |
0.802 |
- |
- |
- |
- |
cytochrome P450 family 26 subfamily C member 1 [Source:HGNC Symbol;Acc:HGNC:20577] |
6. |
EXOC6 |
ENSGALG00000006763 |
119 |
0.794 |
- |
- |
- |
- |
- |
0.794 |
- |
- |
- |
- |
exocyst complex component 6 [Source:NCBI gene;Acc:423807] |
7. |
PIH1D3 |
ENSGALG00000004870 |
1365 |
0.783 |
- |
- |
- |
- |
- |
- |
- |
0.783 |
- |
- |
PIH1 domain containing 3 [Source:HGNC Symbol;Acc:HGNC:28570] |
8. |
GPHB5 |
ENSGALG00000028839 |
45 |
0.775 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.775 |
glycoprotein hormone beta 5 [Source:HGNC Symbol;Acc:HGNC:18055] |
9. |
LZTS3 |
ENSGALG00000016001 |
3 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
leucine zipper tumor suppressor family member 3 [Source:HGNC Symbol;Acc:HGNC:30139] |
10. |
ENSGALG00000028061 |
ENSGALG00000028061 |
2 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
|
11. |
HHIPL2 |
ENSGALG00000045729 |
9 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
HHIP like 2 [Source:HGNC Symbol;Acc:HGNC:25842] |
12. |
ADAM8 |
|
5 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
ADAM metallopeptidase domain 8, transcript variant X4 |
13. |
KL |
ENSGALG00000017068 |
21 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
klotho [Source:HGNC Symbol;Acc:HGNC:6344] |
14. |
IL17F |
ENSGALG00000016677 |
9 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
interleukin 17F |
15. |
GP9 |
GP9 |
6 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
|
16. |
MYH1B |
ENSGALG00000039977 |
3 |
0.769 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.769 |
myosin, heavy chain 1B, skeletal muscle [Source:NCBI gene;Acc:374069] |
17. |
CACNA1I |
ENSGALG00000035051 |
27 |
0.767 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.767 |
calcium voltage-gated channel subunit alpha1 I, transcript variant X3 |
18. |
AK8 |
ENSGALG00000040923 |
10 |
0.762 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.762 |
adenylate kinase 8, transcript variant X1 |
19. |
EPHA2 |
ENSGALG00000039895 |
12 |
0.758 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.758 |
EPH receptor A2 [Source:HGNC Symbol;Acc:HGNC:3386] |
20. |
PLTP |
ENSGALG00000036686 |
79 |
0.757 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.757 |
phospholipid transfer protein [Source:NCBI gene;Acc:428164] |
21. |
HAVCR1 |
ENSGALG00000017362 |
25 |
0.753 |
- |
- |
- |
- |
- |
0.753 |
- |
- |
- |
- |
hepatitis A virus cellular receptor 1 [Source:NCBI gene;Acc:416249] |
22. |
LOC422147 |
ENSGALG00000004113 |
30 |
0.753 |
- |
- |
- |
- |
- |
0.753 |
- |
- |
- |
- |
putative P2Y purinoceptor 10-like |
23. |
DCT |
ENSGALG00000016899 |
37 |
0.752 |
- |
- |
- |
- |
- |
0.752 |
- |
- |
- |
- |
dopachrome tautomerase [Source:NCBI gene;Acc:395775] |
24. |
CDH13 |
ENSGALG00000005483 |
93 |
0.747 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.747 |
cadherin 13 [Source:NCBI gene;Acc:414849] |
25. |
KBTBD8 |
ENSGALG00000007569 |
20 |
0.746 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.746 |
kelch repeat and BTB domain containing 8 [Source:HGNC Symbol;Acc:HGNC:30691] |
26. |
NFATC2 |
ENSGALG00000007963 |
15 |
0.745 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.745 |
nuclear factor of activated T cells 2 [Source:HGNC Symbol;Acc:HGNC:7776] |
27. |
ENSGALG00000006582 |
ENSGALG00000006582 |
8 |
0.742 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.742 |
|
28. |
MAT2A |
ENSGALG00000015366 |
17 |
0.737 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.737 |
methionine adenosyltransferase 2A, transcript variant X1 |
29. |
BLNK |
ENSGALG00000006973 |
85 |
0.735 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.735 |
B cell linker [Source:NCBI gene;Acc:395733] |
30. |
REV-ERBB |
REV-ERBB |
331 |
0.733 |
- |
- |
- |
- |
- |
- |
- |
0.733 |
- |
- |
|
31. |
DDX60 |
|
27 |
0.732 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.732 |
DExD/H-box helicase 60, transcript variant X2 |
32. |
TAF4B |
ENSGALG00000015122 |
28 |
0.73 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.730 |
TATA-box binding protein associated factor 4b [Source:HGNC Symbol;Acc:HGNC:11538] |
33. |
ZNF362 |
ENSGALG00000026558 |
11 |
0.727 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.727 |
zinc finger protein 362 [Source:HGNC Symbol;Acc:HGNC:18079] |
34. |
DENND3 |
ENSGALG00000031380 |
11 |
0.726 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.726 |
DENN domain containing 3 [Source:HGNC Symbol;Acc:HGNC:29134] |
35. |
ENSGALG00000019291 |
ENSGALG00000019291 |
4 |
0.725 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.725 |
|
36. |
PPM1L |
ENSGALG00000009537 |
5 |
0.721 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.721 |
protein phosphatase, Mg2+/Mn2+ dependent 1L [Source:HGNC Symbol;Acc:HGNC:16381] |
37. |
UBA2 |
ENSGALG00000005006 |
243 |
0.72 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.720 |
ubiquitin like modifier activating enzyme 2 [Source:NCBI gene;Acc:415784] |
38. |
BST1 |
ENSGALG00000014509 |
12 |
0.719 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.719 |
bone marrow stromal cell antigen 1 [Source:NCBI gene;Acc:422828] |
39. |
SEC31B |
ENSGALG00000005722 |
13 |
0.718 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.718 |
SEC31 homolog B, COPII coat complex component [Source:HGNC Symbol;Acc:HGNC:23197] |
40. |
FLRT2 |
ENSGALG00000010589 |
490 |
0.717 |
- |
- |
- |
- |
- |
0.717 |
- |
- |
- |
- |
fibronectin leucine rich transmembrane protein 2 [Source:HGNC Symbol;Acc:HGNC:3761] |
41. |
MPP3 |
ENSGALG00000042521 |
1372 |
0.717 |
- |
- |
- |
- |
- |
- |
- |
0.717 |
- |
- |
membrane palmitoylated protein 3 [Source:HGNC Symbol;Acc:HGNC:7221] |
42. |
PXDC1 |
ENSGALG00000012814 |
1163 |
0.714 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.714 |
PX domain containing 1 [Source:HGNC Symbol;Acc:HGNC:21361] |
43. |
ANGPT4 |
ENSGALG00000040755 |
489 |
0.707 |
- |
- |
- |
- |
- |
- |
- |
0.707 |
- |
- |
angiopoietin 4 [Source:HGNC Symbol;Acc:HGNC:487] |
44. |
ATF6 |
ENSGALG00000032278 |
71 |
0.707 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.707 |
activating transcription factor 6 [Source:HGNC Symbol;Acc:HGNC:791] |
45. |
PRDM5 |
ENSGALG00000011963 |
710 |
0.702 |
- |
- |
- |
- |
- |
0.702 |
- |
- |
- |
- |
PR/SET domain 5 [Source:HGNC Symbol;Acc:HGNC:9349] |
46. |
KIAA1024L |
ENSGALG00000027692 |
20 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
KIAA1024 like [Source:HGNC Symbol;Acc:HGNC:33914] |
47. |
ENSGALG00000021716 |
ENSGALG00000021716 |
5 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
|
48. |
MATK |
ENSGALG00000000736 |
4 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
megakaryocyte-associated tyrosine kinase [Source:HGNC Symbol;Acc:HGNC:6906] |
49. |
ENSGALG00000019491 |
ENSGALG00000019491 |
1 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
|
50. |
ITK |
ENSGALG00000003857 |
1 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
IL2 inducible T cell kinase [Source:HGNC Symbol;Acc:HGNC:6171] |
51. |
PCBP3 |
ENSGALG00000004394 |
5 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
poly(rC) binding protein 3, transcript variant X32 |
52. |
PROZ |
ENSGALG00000016832 |
6 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
protein Z, vitamin K dependent plasma glycoprotein [Source:HGNC Symbol;Acc:HGNC:9460] |
53. |
PARM1 |
ENSGALG00000010268 |
13 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
prostate androgen-regulated mucin-like protein 1 [Source:HGNC Symbol;Acc:HGNC:24536] |
54. |
RGS13 |
ENSGALG00000026810 |
8 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
regulator of G protein signaling 13 [Source:HGNC Symbol;Acc:HGNC:9995] |
55. |
B3GALT1 |
ENSGALG00000010931 |
6 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
beta-1,3-galactosyltransferase 1 [Source:HGNC Symbol;Acc:HGNC:916] |
56. |
PCGF2 |
ENSGALG00000018815 |
38 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
polycomb group ring finger 2 [Source:NCBI gene;Acc:425919] |
57. |
ENSGALG00000027565 |
ENSGALG00000027565 |
2 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
|
58. |
CASP10 |
ENSGALG00000046494 |
2 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
caspase 10 [Source:HGNC Symbol;Acc:HGNC:1500] |
59. |
TSGA10 |
ENSGALG00000016757 |
4 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
testis specific 10 [Source:HGNC Symbol;Acc:HGNC:14927] |
60. |
MYO5C |
ENSGALG00000033198 |
36 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
myosin VC [Source:HGNC Symbol;Acc:HGNC:7604] |
61. |
OMG |
ENSGALG00000005594 |
3 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
oligodendrocyte myelin glycoprotein [Source:HGNC Symbol;Acc:HGNC:8135] |
62. |
ENSGALG00000022892 |
ENSGALG00000022892 |
3 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
|
63. |
INTS6L |
ENSGALG00000006157 |
2303 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
integrator complex subunit 6 like, transcript variant X6 |
64. |
KIAA2013 |
ENSGALG00000004533 |
8 |
0.701 |
- |
- |
- |
- |
- |
0.701 |
- |
- |
- |
- |
KIAA2013 [Source:HGNC Symbol;Acc:HGNC:28513] |
65. |
LRFN2 |
ENSGALG00000010050 |
28 |
0.7 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
0.700 |
leucine rich repeat and fibronectin type III domain containing 2 [Source:HGNC Symbol;Acc:HGNC:21226] |
66. |
NSMAF |
ENSGALG00000038838 |
2221 |
0.7 |
- |
- |
- |
- |
- |
0.700 |
- |
- |
- |
- |
neutral sphingomyelinase activation associated factor [Source:HGNC Symbol;Acc:HGNC:8017] |